Skip to main content
U.S. flag

An official website of the United States government

Now is the time! NIA's small business programs offer up to $1.5 million in no-strings-attached funding

Michael-David Kerns
Michael-David KERNS,
Health Scientist Administrator,
Office of Strategic Extramural Programs (OSEP)

If you run a small business, are thinking of starting a small business, or have an idea focused on Alzheimer's disease and Alzheimer’s-related dementias (AD/ADRD) that has a commercial side, then this blog is for you! Whether your focus is therapeutic drug development, systems of care, effects on families, or something else, there are opportunities for you through our small business research and development (R&D) programs – known as SBIR (Small Business Innovation Research) and STTR (Small Business Technology Transfer Research).

Infographic on SBIR. 'Got a big idea about: innovations to support healthy aging and aging in place; technology to reduce burden and improve care and services for older adults; solutions for aging-related problems and needs;  tools to more efficiently assess and diagnose aging-related diseases; interventions to help people with Alzheimer's and related dementias? The National Institute on Aging can help! Funding is available to help turn your ideas into a reality--and help Americans live longer, healthier lives! NIA Small Business Opportunities support small-business concerns & nonprofit research organizations in two primary areas: -Alzheimer's disease and related dementias; -Aging and aging-related diseases. Learn more about NIA's small-business programs and funding opportunities (SBIR/STTR) at .'

NIA’s SBIR and STTR grant mechanisms fund eligible small businesses to conduct aging- and health-focused R&D leading to the development of innovative products and services to improve the health and well-being of older Americans. In fiscal year 2018 (which ends on September 30, 2018), we expect to provide more than $70 million in funding for small business innovation in R&D on aging-related conditions and concerns, including and especially Alzheimer's disease (AD) and AD-related dementias (ADRD).

Funding opportunities

NIA is the lead federal agency sponsoring research on AD/ADRD and has been granted an unprecedented budget to address and develop interventions and therapeutics that prevent, treat, or even cure AD/ADRD.

Consequently, we have a unique opportunity to expand and enrich our small business R&D programs that focus on commercialization—including drug development—of AD/ADRD-focused products and/or services. These products include, but are not limited to:

Apply now!

Truly, we have not seen a better time for applicants with new and different ideas and approaches. We’re supporting awards in areas unrelated to AD/ADRD, as well. We are looking to attract small businesses that have never before considered or participated in these programs. If you’re completely new to the process, a good place to start is the NIH SBIR/STTR site.

The next application deadline—April 5th—is just around the corner. If you can’t make that deadline, please consider preparing an application for September. There are three annual application deadlines: January 5, April 5, and September 5.

For more information, including contact information, learn more about NIA’s small business programs. We look forward to connecting with you about your ideas and innovations!

An official website of the National Institutes of Health